Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
06 Juin 2024 - 10:05PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim
Green, Chairman and Chief Executive Officer, and Jennifer Cote,
Chief Financial Officer, will be presenting to investors at the
14th Annual East Coast IDEAS Conference at the Jay Conference
Center – Bryant Park in New York City on June 12, 2024.
The Company’s presentation is scheduled for
2:45-3:20 PM ET on June 12th. The Company will also host one-on-one
investor meetings throughout the day. The presentation will be
webcast live and can be accessed through the investor relations
section of the Harvard Bioscience website at
https://investor.harvardbioscience.com. A replay will be available
shortly after the presentation has concluded. To schedule a
one-on-one meeting, please contact the Three Part Advisors
conference team at (817) 769-2373 or
lwesley@IDEASconferences.com.
About Harvard Bioscience,
Inc.
Harvard Bioscience, Inc. is a leading developer,
manufacturer and seller of technologies, products and services that
enable fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in North
America, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the
world.
For more information, please visit our website
at www.harvardbioscience.com.
Company Contact:
Harvard BioscienceJennifer Cote, Chief Financial Officer(508)
893-3120
Investor Contacts:
Three Part AdvisorsSandy Martin / Erol Girgin / William
ShelmireHBIO@threepa.com(214) 616-2207
Harvard Bioscience (NASDAQ:HBIO)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Harvard Bioscience (NASDAQ:HBIO)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024